Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

User Fee Hike Will Give Sponsors Clarity On Label, Postmarketing Discussions

Executive Summary

As part of its recommendations for the renewal of the user fee program, FDA is proposing refinements to its "74-day letters" to give sponsors a more detailed schedule of how the application review will proceed

You may also be interested in...



User Fee Inflation Calculations May Need To Change Due To Slow Economic Recovery

The groggy U.S. economy, which already is forcing cut-backs and pay freezes for federal workers, also may push FDA and industry to rethink how to calculate user fee revenue.

User Fee Inflation Calculations May Need To Change Due To Slow Economic Recovery

The groggy U.S. economy, which already is forcing cut-backs and pay freezes for federal workers, also may push FDA and industry to rethink how to calculate user fee revenue.

FDA Wants Promotional “Targets” From Sponsors Throughout Drug Development

Sponsors should provide FDA with proposed promotional claims at the beginning of the drug development process, the agency said in a draft guidance

Related Content

UsernamePublicRestriction

Register

PS047928

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel